Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.45 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.97.
Market Cap
8.45T
Revenue
4.59T
Profits
201.46B
PE Ratio
41.97
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.13% | 1,188,786 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 563.87B | 0.90% | 1,974,873 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 397.88B | 0.95% | 1,180,302 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.56B | 0.63% | 2,553,565 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 293.81B | -0.47% | 3,005,571 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 285.48B | 0.24% | 904,949 | 60.44B |
| 7 | NVS | Novartis AG | 269.49B | 1.54% | 1,332,508 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 186.16B | 0.78% | 6,751,841 | 50.57B |
| 9 | AMGN | Amgen Inc. | 186.05B | -0.29% | 624,975 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 179.33B | 2.76% | 591,225 | 45.20B |
| 11 | ABT | Abbott Laboratories | 158.92B | 0.82% | 4,222,063 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 153.95B | -3.20% | 2,948,169 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 150.73B | 1.67% | 627,326 | 10.58B |
| 14 | PFE | Pfizer Inc. | 145.76B | -0.18% | 10,548,344 | 63.32B |
| 15 | DHR | Danaher Corporation | 132.16B | 1.74% | 852,802 | 24.78B |
| 16 | CVS | CVS Health Corporation | 123.42B | -0.36% | 1,551,113 | 405.62B |
| 17 | SYK | Stryker Corporation | 118.74B | 2.72% | 589,409 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 114.05B | 0.50% | 3,757,711 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.47B | 0.04% | 150,192 | 12.22B |
| 20 | SNY | Sanofi | 106.26B | 1.08% | 1,395,554 | 54.60B |
| 21 | MDT | Medtronic plc | 105.03B | 1.38% | 2,773,545 | 36.36B |
| 22 | GSK | GSK plc | 101.89B | 0.54% | 2,742,721 | 43.29B |
| 23 | MCK | McKesson Corporation | 93.13B | 1.06% | 222,209 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 91.14B | 0.37% | 508,015 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 81.75B | 1.99% | 510,778 | 76.39B |
| 26 | CI | The Cigna Group | 76.73B | 0.16% | 425,459 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.70B | 0.43% | 5,542,789 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.24B | 0.07% | 312,688 | 14.92B |
| 29 | ARGX | argenx SE | 54.81B | -0.99% | 97,489 | 4.74B |
| 30 | COR | Cencora, Inc. | 53.79B | 0.88% | 272,167 | 328.68B |
| 31 | EW | Edwards Lifesciences Corporation | 49.77B | 0.68% | 835,252 | 6.30B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 49.09B | 0.10% | 1,752,502 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 48.39B | 1.05% | 452,725 | 250.74B |
| 34 | MDLN | Medline Inc. | 45.82B | 3.20% | 2,524,166 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.03B | 1.73% | 109,085 | 4.45B |
| 36 | HUM | Humana Inc. | 42.77B | 0.07% | 350,472 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.14B | -0.46% | 432,584 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.30B | 0.76% | 386,383 | 4.29B |
| 39 | HLN | Haleon plc | 39.13B | 2.14% | 5,207,008 | 14.85B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 38.55B | -0.45% | 1,168,711 | 17.35B |
| 41 | A | Agilent Technologies, Inc. | 38.37B | 2.38% | 605,215 | 7.23B |
| 42 | WAT | Waters Corporation | 36.59B | 2.56% | 289,382 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 34.11B | 3.24% | 2,870,498 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.59B | 1.91% | 599,810 | 10.63B |
| 45 | CNC | Centene Corporation | 32.07B | -0.12% | 914,287 | 178.33B |
| 46 | RPRX | Royalty Pharma plc | 31.67B | 0.24% | 724,472 | 2.44B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.38B | -0.61% | 533,777 | - |
| 48 | IQV | IQVIA Holdings Inc. | 31.04B | 1.26% | 422,484 | 16.63B |
| 49 | NTRA | Natera, Inc. | 30.84B | 0.88% | 350,389 | 2.50B |
| 50 | DXCM | DexCom, Inc. | 29.94B | 1.25% | 1,160,363 | 4.82B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.80B | 1.31% | 1,501,313 | 20.98B |
| 52 | ONC | BeOne Medicines AG | 29.71B | -1.31% | 167,948 | 5.70B |
| 53 | BIIB | Biogen Inc. | 28.92B | 1.71% | 175,672 | 9.94B |
| 54 | RMD | ResMed Inc. | 28.17B | 0.99% | 216,510 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 27.19B | 0.10% | 447,791 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 24.69B | 2.05% | 875,204 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 23.70B | -0.87% | 371,032 | 4.39B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.42B | 3.68% | 216,614 | 3.22B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.37B | 1.53% | 73,827 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 23.15B | 0.13% | 59,130 | 3.17B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.18B | 1.62% | 134,078 | 11.28B |
| 62 | LH | Labcorp Holdings Inc. | 21.83B | 1.60% | 115,635 | 14.14B |
| 63 | BNTX | BioNTech SE | 21.53B | -0.44% | 322,379 | 3.23B |
| 64 | INSM | Insmed Incorporated | 20.94B | 2.60% | 1,567,500 | 819.56M |
| 65 | STE | STERIS plc | 20.67B | 0.84% | 116,384 | 5.94B |
| 66 | INCY | Incyte Corporation | 20.58B | 2.36% | 508,760 | 5.36B |
| 67 | ROIV | Roivant Sciences Ltd. | 20.49B | - | 1,193,588 | 8.26M |
| 68 | VTRS | Viatris Inc. | 18.62B | 0.35% | 1,630,779 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 18.47B | -2.18% | 1,833,923 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.07B | 1.12% | 393,599 | 8.41B |
| 71 | GH | Guardant Health, Inc. | 16.47B | -0.52% | 472,222 | 1.08B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.33B | -0.45% | 300,614 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.27B | 0.04% | 648,526 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 14.53B | -0.22% | 195,569 | 4.44B |
| 75 | THC | Tenet Healthcare Corporation | 14.08B | 0.25% | 259,695 | 21.46B |
| 76 | SOLV | Solventum Corporation | 13.91B | 2.02% | 434,803 | 8.26B |
| 77 | MEDP | Medpace Holdings, Inc. | 13.19B | 0.83% | 72,754 | 2.68B |
| 78 | EXEL | Exelixis, Inc. | 13.12B | 0.87% | 368,446 | 2.38B |
| 79 | COO | The Cooper Companies, Inc. | 13.12B | 0.69% | 1,336,298 | 4.23B |
| 80 | ASND | Ascendis Pharma A/S | 13.11B | 2.53% | 148,821 | 998.25M |
| 81 | BBIO | BridgeBio Pharma, Inc. | 12.94B | -1.91% | 414,995 | 579.96M |
| 82 | SNN | Smith & Nephew plc | 12.89B | 2.08% | 801,411 | 6.16B |
| 83 | PEN | Penumbra, Inc. | 12.61B | 0.19% | 94,897 | 1.45B |
| 84 | DVA | DaVita Inc. | 12.54B | 1.71% | 219,238 | 13.84B |
| 85 | ALGN | Align Technology, Inc. | 12.53B | 1.72% | 314,717 | 4.10B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.47B | 1.11% | 988,194 | 13.65B |
| 87 | AXSM | Axsome Therapeutics, Inc. | 12.34B | 1.95% | 315,633 | 708.24M |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.26B | 0.92% | 220,169 | 1.06B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.06B | 1.94% | 1,530,643 | 4.89B |
| 90 | FMS | Fresenius Medical Care AG | 11.77B | 2.32% | 250,877 | 22.32B |
| 91 | ICLR | ICON Public Limited Company | 11.60B | -0.47% | 282,729 | 8.25B |
| 92 | RVTY | Revvity, Inc. | 11.45B | 2.31% | 392,373 | 2.90B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.06B | -0.08% | 339,956 | 3.58B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.01B | 0.53% | 1,992,502 | - |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.00B | 0.63% | 774,934 | 3.24B |
| 96 | GMED | Globus Medical, Inc. | 10.98B | 3.30% | 404,465 | 3.10B |
| 97 | PODD | Insulet Corporation | 10.95B | 4.30% | 415,161 | 2.90B |
| 98 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.94B | 1.54% | 68,074 | 1.13B |
| 99 | MOH | Molina Healthcare, Inc. | 10.45B | 1.08% | 387,311 | 43.10B |
| 100 | EHC | Encompass Health Corporation | 10.30B | 2.65% | 165,366 | 6.07B |
| 101 | BAX | Baxter International Inc. | 10.08B | 1.46% | 1,550,263 | 11.32B |
| 102 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.08B | -3.10% | 407,807 | 622.01M |
| 103 | RGC | Regencell Bioscience Holdings Limited | 9.90B | -6.59% | 39,870 | - |
| 104 | NUVL | Nuvalent, Inc. | 9.72B | 39.09% | 44,019,285 | - |
| 105 | MASI | Masimo Corporation | 9.42B | 0.01% | 294,149 | 1.56B |
| 106 | ENSG | The Ensign Group, Inc. | 9.17B | 1.18% | 325,488 | 5.27B |
| 107 | CYTK | Cytokinetics, Incorporated | 9.16B | -0.68% | 470,072 | 105.82M |
| 108 | HSIC | Henry Schein, Inc. | 9.04B | 1.63% | 504,124 | 13.38B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.99B | 0.13% | 203,128 | 4.03B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.93B | 0.37% | 51,490 | 417.30M |
| 111 | UHS | Universal Health Services, Inc. | 8.78B | 1.52% | 354,956 | 17.76B |
| 112 | BRKR | Bruker Corporation | 8.60B | 0.37% | 507,799 | 3.46B |
| 113 | TECH | Bio-Techne Corporation | 8.42B | 2.09% | 879,483 | 1.21B |
| 114 | TEM | Tempus AI, Inc. | 8.38B | -3.93% | 2,736,550 | 1.36B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.34B | -0.58% | 309,740 | 1.51B |
| 116 | ABVX | ABIVAX Société Anonyme | 8.20B | -1.77% | 477,564 | 5.67M |
| 117 | CORT | Corcept Therapeutics Incorporated | 8.07B | 2.54% | 235,465 | 769.10M |
| 118 | OSCR | Oscar Health, Inc. | 8.01B | -2.88% | 4,239,623 | 13.30B |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.86B | 0.80% | 100,396 | 2.59B |
| 120 | QGEN | Qiagen N.V. | 7.57B | 0.99% | 568,259 | 2.10B |
| 121 | GKOS | Glaukos Corporation | 7.46B | 4.21% | 288,033 | 551.35M |
| 122 | HQY | HealthEquity, Inc. | 7.45B | 1.43% | 135,469 | 1.34B |
| 123 | IBRX | ImmunityBio, Inc. | 7.42B | -1.26% | 3,909,614 | 140.98M |
| 124 | RGEN | Repligen Corporation | 7.37B | 4.19% | 575,599 | 763.34M |
| 125 | ATR | AptarGroup, Inc. | 7.34B | 2.69% | 59,376 | 3.87B |
| 126 | ALKS | Alkermes plc | 7.25B | 2.52% | 838,982 | 1.56B |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 6.91B | -2.07% | 111,139 | 7.46M |
| 128 | AVTR | Avantor, Inc. | 6.71B | 1.39% | 5,107,024 | 6.55B |
| 129 | PCVX | Vaxcyte, Inc. | 6.68B | -0.19% | 237,740 | - |
| 130 | LNTH | Lantheus Holdings, Inc. | 6.40B | -1.66% | 156,425 | 1.55B |
| 131 | PTGX | Protagonist Therapeutics, Inc. | 6.40B | 1.52% | 155,857 | 74.06M |
| 132 | GRFS | Grifols, S.A. | 6.32B | 0.55% | 344,212 | 8.58B |
| 133 | IMVT | Immunovant, Inc. | 6.25B | -1.17% | 431,045 | - |
| 134 | HIMS | Hims & Hers Health, Inc. | 6.25B | -0.63% | 9,888,687 | 2.37B |
| 135 | SYRE | Spyre Therapeutics, Inc. | 6.17B | -1.36% | 419,365 | - |
| 136 | CNTA | Centessa Pharmaceuticals plc | 6.14B | - | 513,076 | 15.00M |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.10B | -1.94% | 194,200 | - |
| 138 | KYMR | Kymera Therapeutics, Inc. | 6.06B | -0.32% | 195,649 | 51.48M |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.98B | 1.75% | 500,685 | 827.11M |
| 140 | TFX | Teleflex Incorporated | 5.93B | 1.62% | 127,520 | 2.13B |
| 141 | TGTX | TG Therapeutics, Inc. | 5.93B | 2.10% | 506,414 | 700.35M |
| 142 | CHE | Chemed Corporation | 5.87B | 1.18% | 68,943 | 2.54B |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.87B | -0.38% | 181,383 | 217.17M |
| 144 | LEGN | Legend Biotech Corporation | 5.86B | 0.10% | 542,185 | 1.14B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 5.65B | -1.00% | 104,819 | 569.61M |
| 146 | LQDA | Liquidia Corporation | 5.56B | -2.18% | 577,829 | 288.07M |
| 147 | PACS | PACS Group, Inc. | 5.53B | -0.33% | 128,956 | 5.43B |
| 148 | BLCO | Bausch + Lomb Corporation | 5.53B | 2.17% | 168,228 | 5.21B |
| 149 | BLTE | Belite Bio, Inc | 5.42B | -1.27% | 90,910 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 5.36B | 0.61% | 895,274 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.28B | 0.66% | 261,718 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 4.98B | 0.68% | 623,224 | 7.50M |
| 153 | STVN | Stevanato Group S.p.A. | 4.96B | 0.94% | 58,625 | 1.39B |
| 154 | CRSP | CRISPR Therapeutics AG | 4.89B | -1.78% | 535,486 | 4.10M |
| 155 | CGON | CG Oncology, Inc. | 4.83B | 0.74% | 369,378 | 5.07M |
| 156 | HNGE | Hinge Health, Inc. | 4.83B | -0.70% | 442,494 | 646.34M |
| 157 | LGND | Ligand Pharmaceuticals Incorporated | 4.77B | 0.15% | 45,411 | 274.48M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.73B | 3.72% | 1,125,059 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.60B | 1.73% | 1,146,312 | 1.19B |
| 160 | TNGX | Tango Therapeutics, Inc. | 4.59B | 2.52% | 2,693,363 | 56.99M |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 4.52B | 3.43% | 497,028 | 3.05B |
| 162 | BLLN | BillionToOne, Inc. | 4.46B | 2.59% | 269,753 | 354.54M |
| 163 | TVTX | Travere Therapeutics, Inc. | 4.46B | 1.76% | 456,356 | 536.20M |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | 0.32% | 199,698 | 1.34M |
| 165 | CELC | Celcuity Inc. | 4.43B | 3.89% | 461,850 | - |
| 166 | TWST | Twist Bioscience Corporation | 4.32B | -0.84% | 649,787 | 409.48M |
| 167 | RDNT | RadNet, Inc. | 4.32B | 1.33% | 114,064 | 2.14B |
| 168 | MMED | MiniMed Group, Inc. | 4.27B | 2.15% | 340,187 | 3.10B |
| 169 | LIVN | LivaNova PLC | 4.20B | 2.17% | 188,053 | 1.43B |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.01B | 1.68% | 231,476 | 1.54B |
| 171 | NVST | Envista Holdings Corporation | 3.93B | 3.11% | 860,612 | 2.81B |
| 172 | MANE | Veradermics, Incorporated | 3.90B | 3.28% | 146,864 | - |
| 173 | ERAS | Erasca, Inc. | 3.88B | -3.11% | 1,342,651 | - |
| 174 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.16% | 545,076 | 596.96M |
| 175 | VCYT | Veracyte, Inc. | 3.83B | 1.63% | 204,072 | 541.74M |
| 176 | ORKA | Oruka Therapeutics, Inc. | 3.82B | -1.06% | 468,315 | - |
| 177 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.81B | 0.94% | 133,782 | 754.05M |
| 178 | TXG | 10x Genomics, Inc. | 3.76B | 1.53% | 766,606 | 638.78M |
| 179 | DOCS | Doximity, Inc. | 3.72B | 0.15% | 867,391 | 644.86M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.70B | -0.30% | 337,349 | 1.10B |
| 181 | WAY | Waystar Holding Corp. | 3.70B | 1.53% | 585,626 | 1.16B |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.67B | -2.18% | 229,359 | - |
| 183 | ALHC | Alignment Healthcare, Inc. | 3.66B | 15.44% | 5,056,301 | 4.26B |
| 184 | IRTC | iRhythm Holdings, Inc. | 3.64B | 3.24% | 126,375 | 787.85M |
| 185 | HAE | Haemonetics Corporation | 3.62B | 6.24% | 651,454 | 1.33B |
| 186 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.57B | 1.15% | 246,592 | 18.07M |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | -2.29% | 234,971 | 22.57M |
| 188 | OGN | Organon & Co. | 3.52B | - | 556,570 | 6.16B |
| 189 | ICUI | ICU Medical, Inc. | 3.50B | 1.99% | 104,188 | 2.16B |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.35B | -1.20% | 814,524 | - |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.33B | 2.24% | 272,039 | 2.23B |
| 192 | OPCH | Option Care Health, Inc. | 3.26B | 3.49% | 890,815 | 5.67B |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.21B | 1.52% | 50,528 | 803.79M |
| 194 | ITGR | Integer Holdings Corporation | 3.17B | 1.57% | 76,735 | 1.86B |
| 195 | DNLI | Denali Therapeutics Inc. | 3.15B | 1.69% | 551,567 | - |
| 196 | BKD | Brookdale Senior Living Inc. | 3.00B | 5.86% | 1,382,805 | 3.00B |
| 197 | NHC | National HealthCare Corporation | 3.00B | 2.15% | 45,691 | 1.53B |
| 198 | RLAY | Relay Therapeutics, Inc. | 2.96B | -0.59% | 757,388 | 10.68M |
| 199 | BEAM | Beam Therapeutics Inc. | 2.93B | -1.21% | 607,828 | 164.01M |
| 200 | LFST | LifeStance Health Group, Inc. | 2.90B | 1.77% | 298,952 | 1.49B |
| 201 | RCUS | Arcus Biosciences, Inc. | 2.88B | -1.67% | 302,748 | 236.00M |
| 202 | GPCR | Structure Therapeutics Inc. | 2.86B | 6.41% | 879,240 | - |
| 203 | WRBY | Warby Parker Inc. | 2.84B | -1.51% | 884,181 | 890.57M |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.84B | 2.17% | 226,791 | - |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | 2.14% | 450,128 | 415.62M |
| 206 | PRVA | Privia Health Group, Inc. | 2.75B | 1.96% | 274,730 | 2.25B |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 2.70B | 1.02% | 403,725 | 295.41M |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 2.65B | 3.44% | 174,376 | 535.08M |
| 209 | SUPN | Supernus Pharmaceuticals, Inc. | 2.64B | 2.20% | 77,141 | 776.83M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.62B | 1.95% | 95,819 | 1.46B |
| 211 | GRAL | GRAIL, Inc. | 2.58B | -2.45% | 154,015 | 156.12M |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | -6.89% | 1,904,803 | 225.27M |
| 213 | IRON | Disc Medicine, Inc. | 2.57B | 2.14% | 165,130 | - |
| 214 | KLRA | Kailera Therapeutics, Inc. | 2.51B | -1.78% | 287,078 | - |
| 215 | GMRS | GMR Solutions Inc. | 2.47B | 4.63% | 219,955 | 5.83B |
| 216 | TMDX | TransMedics Group, Inc. | 2.47B | 0.39% | 337,076 | 635.89M |
| 217 | HTFL | HeartFlow, Inc. | 2.47B | 0.49% | 214,773 | 191.42M |
| 218 | DFTX | Definium Therapeutics, Inc. | 2.42B | -3.48% | 650,976 | - |
| 219 | ALMS | Alumis Inc. | 2.39B | -1.21% | 820,310 | 8.40M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.34B | 0.59% | 364,236 | 3.37B |
| 221 | PBH | Prestige Consumer Healthcare Inc. | 2.33B | 2.87% | 274,651 | 1.09B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.25B | 0.39% | 133,737 | 865.00K |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.24B | 1.54% | 238,639 | 229.58M |
| 224 | VERA | Vera Therapeutics, Inc. | 2.24B | -1.92% | 343,969 | - |
| 225 | AXGN | Axogen, Inc. | 2.23B | 1.35% | 186,057 | 238.11M |
| 226 | CLOV | Clover Health Investments, Corp. | 2.21B | 7.14% | 7,524,125 | 2.21B |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.19B | 0.99% | 120,330 | 256.28M |
| 228 | PHVS | Pharvaris N.V. | 2.19B | -0.60% | 283,958 | - |
| 229 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | 2.96% | 479,736 | 670.00M |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.13B | -0.47% | 1,209,405 | 885.72M |
| 231 | ELVN | Enliven Therapeutics, Inc. | 2.10B | 2.53% | 501,196 | - |
| 232 | IMNM | Immunome, Inc. | 2.08B | -1.42% | 269,172 | 4.02M |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.07B | 0.63% | 1,535,578 | 3.68B |
| 234 | SEM | Select Medical Holdings Corporation | 2.06B | 0.18% | 181,723 | 5.52B |
| 235 | PGNY | Progyny, Inc. | 2.03B | 0.17% | 299,551 | 1.29B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 0.06% | 237,378 | 298.30M |
| 237 | NVCR | NovoCure Limited | 1.99B | 2.20% | 318,035 | 674.41M |
| 238 | NEOG | Neogen Corporation | 1.99B | 0.77% | 562,118 | 870.56M |
| 239 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | 4.45% | 240,425 | 899.11M |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | 5.02% | 929,829 | - |
| 241 | BHC | Bausch Health Companies Inc. | 1.90B | -0.29% | 440,511 | 10.53B |
| 242 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -0.81% | 322,509 | - |
| 243 | HCM | HUTCHMED (China) Limited | 1.89B | -2.30% | 24,725 | 548.51M |
| 244 | ADMA | ADMA Biologics, Inc. | 1.88B | 0.81% | 738,043 | 509.86M |
| 245 | OMCL | Omnicell, Inc. | 1.88B | -1.31% | 115,177 | 1.23B |
| 246 | VCEL | Vericel Corporation | 1.88B | 2.85% | 169,914 | 292.09M |
| 247 | MD | Pediatrix Medical Group, Inc. | 1.87B | 3.69% | 208,837 | 1.93B |
| 248 | MESO | Mesoblast Limited | 1.87B | 1.92% | 85,302 | 65.38M |
| 249 | KOD | Kodiak Sciences Inc. | 1.86B | 0.71% | 202,528 | - |
| 250 | NKTR | Nektar Therapeutics | 1.86B | -2.95% | 373,992 | 55.63M |
| 251 | ASTH | Astrana Health, Inc. | 1.85B | -2.58% | 196,990 | 3.53B |
| 252 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.83% | 91,230 | 1.20B |
| 253 | ZLAB | Zai Lab Limited | 1.85B | -0.18% | 396,356 | 453.28M |
| 254 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -4.30% | 2,274,242 | 66.09M |
| 255 | NBTX | Nanobiotix S.A. | 1.80B | -6.49% | 60,522 | 38.27M |
| 256 | STOK | Stoke Therapeutics, Inc. | 1.80B | -0.45% | 78,669 | 32.08M |
| 257 | SGRY | Surgery Partners, Inc. | 1.79B | -0.04% | 206,313 | 3.34B |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.79B | - | 799,261 | 52.04M |
| 259 | UFPT | UFP Technologies, Inc. | 1.77B | 0.90% | 79,321 | 608.85M |
| 260 | IOVA | Iovance Biotherapeutics, Inc. | 1.75B | -2.25% | 3,740,989 | 285.61M |
| 261 | VRDN | Viridian Therapeutics, Inc. | 1.74B | 0.45% | 283,215 | 70.92M |
| 262 | PLSE | Pulse Biosciences, Inc. | 1.74B | 0.93% | 56,739 | 751.00K |
| 263 | ZYME | Zymeworks Inc. | 1.73B | -0.73% | 220,074 | 81.26M |
| 264 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 2.01% | 80,868 | 923.71M |
| 265 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | -2.26% | 7,265,308 | 66.41M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.70B | -3.33% | 66,572 | 20.00M |
| 267 | ADUS | Addus HomeCare Corporation | 1.69B | 2.00% | 39,881 | 1.45B |
| 268 | INVA | Innoviva, Inc. | 1.67B | 1.34% | 189,177 | 420.69M |
| 269 | BHVN | Biohaven Ltd. | 1.67B | -0.54% | 1,193,953 | - |
| 270 | PRCT | PROCEPT BioRobotics Corporation | 1.66B | 2.96% | 420,965 | 322.02M |
| 271 | GENB | Generate Biomedicines, Inc. | 1.65B | 0.63% | 219,587 | 30.30M |
| 272 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | 0.19% | 582,640 | 2.18B |
| 273 | QURE | uniQure N.V. | 1.64B | -3.44% | 295,040 | 18.09M |
| 274 | WGS | GeneDx Holdings Corp. | 1.64B | 6.58% | 534,206 | 442.68M |
| 275 | AGL | agilon health, inc. | 1.63B | 2.72% | 65,611 | 5.82B |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -0.58% | 466,295 | 66.05M |
| 277 | NUVB | Nuvation Bio Inc. | 1.62B | -3.12% | 6,150,824 | 143.05M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.61B | 3.17% | 126,535 | 367.34M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.59B | -1.92% | 3,529,063 | 71.78M |
| 280 | ABCL | AbCellera Biologics Inc. | 1.58B | -4.24% | 2,813,003 | 79.21M |
| 281 | FTRE | Fortrea Holdings Inc. | 1.56B | -0.42% | 222,765 | 2.71B |
| 282 | AAPG | Ascentage Pharma Group International | 1.56B | 0.12% | 693 | 82.08M |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.56B | -0.28% | 1,081,603 | 7.47M |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.54B | 2.71% | 317,743 | 217.17M |
| 285 | PRGO | Perrigo Company plc | 1.54B | -4.22% | 1,494,764 | 4.18B |
| 286 | TYRA | Tyra Biosciences, Inc. | 1.52B | -4.52% | 390,387 | - |
| 287 | CMPS | COMPASS Pathways plc | 1.50B | -4.94% | 1,492,567 | - |
| 288 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -0.36% | 72,903 | - |
| 289 | STAA | STAAR Surgical Company | 1.49B | -0.07% | 109,128 | 290.38M |
| 290 | ANAB | AnaptysBio, Inc. | 1.49B | -0.41% | 128,867 | 232.39M |
| 291 | SION | Sionna Therapeutics, Inc. | 1.48B | -2.30% | 88,532 | - |
| 292 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.47B | 1.77% | 237,031 | -665.00K |
| 293 | CAPR | Capricor Therapeutics, Inc. | 1.46B | -3.75% | 354,205 | 11.13M |
| 294 | NEO | NeoGenomics, Inc. | 1.46B | 2.10% | 397,214 | 745.97M |
| 295 | AVAH | Aveanna Healthcare Holdings Inc. | 1.45B | 0.60% | 275,498 | 2.52B |
| 296 | HCSG | Healthcare Services Group, Inc. | 1.44B | 2.39% | 103,158 | 1.85B |
| 297 | IMCR | Immunocore Holdings plc | 1.44B | 1.80% | 74,778 | 412.81M |
| 298 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | -0.02% | 754,248 | 114.48M |
| 299 | SLS | SELLAS Life Sciences Group, Inc. | 1.42B | -4.26% | 3,016,740 | - |
| 300 | ATAI | AtaiBeckley Inc. | 1.41B | 0.52% | 1,548,980 | 3.49M |
| 301 | VIR | Vir Biotechnology, Inc. | 1.40B | -1.78% | 461,323 | 65.50M |
| 302 | GLUE | Monte Rosa Therapeutics, Inc. | 1.39B | -3.00% | 344,068 | 42.95M |
| 303 | NVAX | Novavax, Inc. | 1.39B | -1.74% | 2,264,518 | 596.34M |
| 304 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -2.39% | 73,355 | - |
| 305 | GHRS | GH Research PLC | 1.38B | 0.30% | 51,996 | - |
| 306 | ARDX | Ardelyx, Inc. | 1.37B | 0.27% | 1,170,809 | 427.68M |
| 307 | MBX | MBX Biosciences, Inc. | 1.37B | -0.59% | 107,743 | - |
| 308 | ATRC | AtriCure, Inc. | 1.37B | 0.61% | 109,845 | 552.16M |
| 309 | ENOV | Enovis Corporation | 1.37B | 0.46% | 253,751 | 2.28B |
| 310 | SEPN | Septerna, Inc. | 1.37B | -0.23% | 65,382 | 72.26M |
| 311 | ALMR | Alamar Biosciences, Inc. | 1.36B | 2.19% | 30,453 | 87.16M |
| 312 | IART | Integra LifeSciences Holdings Corporation | 1.34B | 1.33% | 125,805 | 1.64B |
| 313 | ALVO | Alvotech | 1.32B | -0.47% | 832,170 | 562.04M |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.32B | -0.05% | 193,050 | - |
| 315 | URGN | UroGen Pharma Ltd. | 1.31B | -1.28% | 203,122 | 140.49M |
| 316 | PGEN | Precigen, Inc. | 1.31B | 2.80% | 1,181,254 | 31.60M |
| 317 | MPLT | MapLight Therapeutics, Inc. | 1.31B | -2.14% | 114,321 | - |
| 318 | PAHC | Phibro Animal Health Corporation | 1.31B | 1.32% | 52,943 | 1.50B |
| 319 | ARDT | Ardent Health, Inc. | 1.30B | 2.83% | 112,506 | 6.43B |
| 320 | AHCO | AdaptHealth Corp. | 1.30B | 0.88% | 170,170 | 3.29B |
| 321 | INBX | Inhibrx Biosciences, Inc. | 1.30B | -0.91% | 55,316 | 1.30M |
| 322 | MAZE | Maze Therapeutics, Inc. | 1.29B | -1.04% | 116,606 | 20.00M |
| 323 | BLFS | BioLife Solutions, Inc. | 1.29B | 0.92% | 149,004 | 101.66M |
| 324 | MLTX | MoonLake Immunotherapeutics | 1.29B | -3.00% | 478,035 | - |
| 325 | BFLY | Butterfly Network, Inc. | 1.28B | 2.09% | 2,211,930 | 102.92M |
| 326 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.28B | -1.88% | 653,967 | 204.73M |
| 327 | HROW | Harrow, Inc. | 1.27B | 2.84% | 303,539 | 268.68M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.27B | 4.30% | 582,213 | 787.08M |
| 329 | DMRA | Damora Therapeutics, Inc. | 1.26B | -1.96% | 82,577 | - |
| 330 | TNDM | Tandem Diabetes Care, Inc. | 1.24B | -2.11% | 452,746 | 1.03B |
| 331 | TDOC | Teladoc Health, Inc. | 1.24B | -3.25% | 1,112,875 | 2.51B |
| 332 | IMTX | Immatics N.V. | 1.23B | -0.76% | 294,383 | 43.00M |
| 333 | SVRA | Savara Inc. | 1.22B | -4.94% | 1,596,278 | - |
| 334 | IRMD | IRADIMED CORPORATION | 1.22B | 0.83% | 45,079 | 86.28M |
| 335 | INSP | Inspire Medical Systems, Inc. | 1.21B | 0.41% | 114,797 | 915.25M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.21B | 3.39% | 72,924 | - |
| 337 | AHG | Akso Health Group | 1.20B | 5.26% | 3,715 | 14.84M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.19B | -1.08% | 224,996 | 3.42B |
| 339 | COAG | Hemab Therapeutics Holdings, Inc. | 1.17B | 3.96% | 57,319 | - |
| 340 | AVNS | Avanos Medical, Inc. | 1.17B | 0.04% | 220,167 | 715.90M |
| 341 | CDNA | CareDx, Inc. | 1.14B | 0.23% | 119,239 | 412.82M |
| 342 | KMTS | Kestra Medical Technologies, Ltd. | 1.13B | -1.98% | 54,540 | 83.72M |
| 343 | PNTG | The Pennant Group, Inc. | 1.12B | 2.87% | 90,765 | 1.02B |
| 344 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 3.76% | 73,625 | 796.33M |
| 345 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.23% | 1,293,686 | 71.80M |
| 346 | ZBIO | Zenas BioPharma, Inc. | 1.11B | -0.34% | 101,605 | 10.00M |
| 347 | XERS | Xeris Biopharma Holdings, Inc. | 1.11B | 2.80% | 557,004 | 314.85M |
| 348 | CNMD | CONMED Corporation | 1.09B | 4.94% | 100,709 | 1.37B |
| 349 | SDGR | Schrödinger, Inc. | 1.08B | 0.21% | 340,578 | 254.91M |
| 350 | OPK | OPKO Health, Inc. | 1.07B | -1.05% | 730,989 | 581.12M |
| 351 | OMDA | Omada Health, Inc. | 1.06B | 0.11% | 231,862 | 283.30M |
| 352 | MNKD | MannKind Corporation | 1.06B | 1.47% | 1,607,876 | 360.78M |
| 353 | CRON | Cronos Group Inc. | 1.04B | 0.18% | 591,226 | 159.54M |
| 354 | AZTA | Azenta, Inc. | 1.04B | -0.35% | 241,654 | 596.48M |
| 355 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.95% | 31,080 | 8.28M |
| 356 | INNV | InnovAge Holding Corp. | 1.02B | 2.17% | 149,727 | 949.17M |
| 357 | ABSI | Absci Corporation | 1.02B | - | 1,578,536 | 1.84M |
| 358 | EVO | Evotec SE | 1.01B | -2.14% | 10,558 | 859.03M |
| 359 | AORT | Artivion, Inc. | 1.01B | 2.06% | 278,756 | 458.69M |
| 360 | PSNL | Personalis, Inc. | 993.80M | -5.48% | 1,331,493 | 64.52M |
| 361 | DBVT | DBV Technologies S.A. | 970.44M | -0.47% | 70,322 | 5.74M |
| 362 | QDEL | QuidelOrtho Corporation | 960.13M | -2.66% | 383,240 | 2.66B |
| 363 | EYPT | EyePoint, Inc. | 954.11M | -0.61% | 267,539 | 7.61M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 951.02M | 1.94% | 60,165 | 787.69M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 930.11M | 8.27% | 50,271 | - |
| 366 | NUTX | Nutex Health Inc. | 924.44M | -0.05% | 41,587 | 879.95M |
| 367 | PCRX | Pacira BioSciences, Inc. | 922.32M | 2.54% | 68,059 | 734.86M |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 920.79M | -1.79% | 782,346 | - |
| 369 | AVR | Anteris Technologies Global Corp. | 914.11M | -3.85% | 261,993 | 1.85M |
| 370 | PHAR | Pharming Group N.V. | 906.06M | -2.42% | 1,664 | 369.49M |
| 371 | SPRY | ARS Pharmaceuticals, Inc. | 902.67M | 1.11% | 151,480 | 98.99M |
| 372 | OLMA | Olema Pharmaceuticals, Inc. | 896.19M | 3.01% | 323,775 | - |
| 373 | GDRX | GoodRx Holdings, Inc. | 883.94M | -0.76% | 901,313 | 787.89M |
| 374 | AMPH | Amphastar Pharmaceuticals, Inc. | 878.99M | 2.81% | 165,634 | 720.53M |
| 375 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 513,660 | 238.37M |
| 376 | XNCR | Xencor, Inc. | 865.23M | 2.28% | 287,818 | 97.36M |
| 377 | INMD | InMode Ltd. | 857.24M | 0.22% | 176,261 | 374.64M |
| 378 | JBIO | Jade Biosciences, Inc. | 855.97M | -3.74% | 506,305 | - |
| 379 | LBRX | LB Pharmaceuticals Inc | 846.60M | 0.42% | 63,553 | - |
| 380 | TBPH | Theravance Biopharma, Inc. | 844.95M | 0.61% | 109,175 | 109.78M |
| 381 | ABUS | Arbutus Biopharma Corporation | 833.61M | -0.47% | 353,373 | 191.45M |
| 382 | ANNX | Annexon, Inc. | 833.14M | -0.68% | 559,646 | - |
| 383 | MGTX | MeiraGTx Holdings plc | 829.78M | -1.43% | 130,254 | 79.76M |
| 384 | LXRX | Lexicon Pharmaceuticals, Inc. | 828.43M | -0.80% | 420,593 | 69.64M |
| 385 | ETON | Eton Pharmaceuticals, Inc. | 825.47M | 0.62% | 55,113 | 86.93M |
| 386 | ODTX | Odyssey Therapeutics, Inc. | 820.83M | 1.64% | 61,438 | 2.98M |
| 387 | IVA | Inventiva S.A. | 819.08M | -5.12% | 367,654 | 7.94M |
| 388 | DRTS | Alpha Tau Medical Ltd. | 817.90M | -2.26% | 188,666 | - |
| 389 | JANX | Janux Therapeutics, Inc. | 816.58M | -0.89% | 137,797 | 13.73M |
| 390 | LMRI | Lumexa Imaging Holdings, Inc. | 816.21M | 4.49% | 282,178 | 1.03B |
| 391 | ESPR | Esperion Therapeutics, Inc. | 809.62M | -0.16% | 3,583,169 | 418.24M |
| 392 | CERT | Certara, Inc. | 808.94M | -0.38% | 1,025,257 | 419.75M |
| 393 | PHAT | Phathom Pharmaceuticals, Inc. | 790.33M | -0.50% | 202,316 | 204.89M |
| 394 | KURA | Kura Oncology, Inc. | 778.55M | 2.45% | 725,203 | 71.64M |
| 395 | CGEM | Cullinan Therapeutics, Inc. | 777.44M | -4.74% | 532,056 | - |
| 396 | ORIC | ORIC Pharmaceuticals, Inc. | 776.38M | -0.40% | 323,461 | - |
| 397 | SANA | Sana Biotechnology, Inc. | 775.04M | 3.53% | 2,981,963 | - |
| 398 | ZVRA | Zevra Therapeutics, Inc. | 775.00M | 8.44% | 2,936,244 | 122.29M |
| 399 | BVS | Bioventus Inc. | 760.17M | 1.68% | 138,812 | 576.30M |
| 400 | HSTM | HealthStream, Inc. | 755.50M | 0.82% | 55,438 | 311.78M |
| 401 | SSII | SS Innovations International, Inc. | 725.78M | 2.83% | 36,307 | 48.47M |
| 402 | GERN | Geron Corporation | 721.71M | -0.44% | 5,492,235 | 196.12M |
| 403 | REPL | Replimune Group, Inc. | 721.68M | -2.56% | 708,000 | - |
| 404 | EVMN | Evommune, Inc. | 711.36M | -2.18% | 136,888 | 10.00M |
| 405 | OMER | Omeros Corporation | 709.28M | -0.51% | 629,635 | 9.89M |
| 406 | AURA | Aura Biosciences, Inc. | 702.61M | -1.70% | 161,623 | - |
| 407 | CBLL | CeriBell, Inc. | 697.39M | 1.32% | 144,029 | 95.07M |
| 408 | VOR | Vor Biopharma Inc. | 692.49M | -3.84% | 383,349 | - |
| 409 | BIOA | BioAge Labs, Inc. | 691.24M | 0.26% | 38,063 | 10.32M |
| 410 | ANRO | Alto Neuroscience, Inc. | 685.98M | 7.29% | 303,252 | - |
| 411 | SIBN | SI-BONE, Inc. | 681.20M | 2.61% | 87,571 | 206.22M |
| 412 | NNNN | Anbio Biotechnology | 680.31M | -9.99% | 29,599 | 8.65M |
| 413 | AVTX | Avalo Therapeutics, Inc. | 674.42M | 0.71% | 205,837 | 59.00K |
| 414 | CRMD | CorMedix Inc. | 671.94M | 0.29% | 405,109 | 400.05M |
| 415 | OCS | Oculis Holding AG | 656.42M | 1.49% | 453,785 | 1.40M |
| 416 | DSGN | Design Therapeutics, Inc. | 651.43M | -0.29% | 114,868 | - |
| 417 | SLDB | Solid Biosciences Inc. | 634.51M | 0.55% | 235,194 | - |
| 418 | CTMX | CytomX Therapeutics, Inc. | 631.34M | -1.36% | 790,394 | 35.54M |
| 419 | DRUG | Bright Minds Biosciences Inc. | 629.81M | 2.65% | 179,065 | - |
| 420 | CSTL | Castle Biosciences, Inc. | 624.19M | 2.29% | 44,365 | 339.92M |
| 421 | BBNX | Beta Bionics, Inc. | 620.74M | 0.43% | 416,125 | 110.24M |
| 422 | SGP | SpyGlass Pharma, Inc. | 618.56M | -1.25% | 23,349 | - |
| 423 | TENX | Tenax Therapeutics, Inc. | 617.63M | -0.47% | 949,754 | - |
| 424 | ALLO | Allogene Therapeutics, Inc. | 614.38M | -3.78% | 2,142,486 | 22.00K |
| 425 | TLRY | Tilray Brands, Inc. | 614.31M | 2.39% | 2,713,238 | 858.28M |
| 426 | CADL | Candel Therapeutics, Inc. | 614.00M | -1.41% | 577,666 | - |
| 427 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 607.21M | -2.57% | 196,967 | - |
| 428 | RLMD | Relmada Therapeutics, Inc. | 601.02M | 0.17% | 341,157 | - |
| 429 | ACRS | Aclaris Therapeutics, Inc. | 600.55M | -1.38% | 290,091 | 8.37M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 585.56M | 2.81% | 52,176 | 343.52M |
| 431 | CBIO | Crescent Biopharma, Inc. | 575.36M | 0.20% | 24,659 | 11.88M |
| 432 | BWAY | BrainsWay Ltd. | 573.62M | -1.98% | 18,437 | 56.22M |
| 433 | PHR | Phreesia, Inc. | 569.29M | -1.39% | 221,099 | 495.59M |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 567.64M | 1.99% | 80,859 | 299.77M |
| 435 | ACHV | Achieve Life Sciences, Inc. | 561.55M | -0.18% | 322,728 | - |
| 436 | IMMX | Immix Biopharma, Inc. | 552.04M | 0.51% | 478,933 | - |
| 437 | TRAX | First Tracks Biotherapeutics, Inc. | 546.76M | -0.51% | 116,373 | - |
| 438 | MDXG | MiMedx Group, Inc. | 546.63M | -0.81% | 338,919 | 389.42M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 545.40M | -1.34% | 43,553 | 117.05M |
| 440 | NPCE | NeuroPace, Inc. | 538.34M | 1.02% | 26,362 | 99.53M |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 529.23M | -2.28% | 810,681 | 361.51M |
| 442 | XOMA | XOMA Royalty Corporation | 528.96M | 0.62% | 24,175 | 48.56M |
| 443 | FLGT | Fulgent Genetics, Inc. | 523.99M | 0.76% | 66,905 | 320.35M |
| 444 | EVH | Evolent Health, Inc. | 523.04M | -0.21% | 1,091,683 | 1.89B |
| 445 | TECX | Tectonic Therapeutic, Inc. | 518.34M | -5.60% | 73,395 | - |
| 446 | CTKB | Cytek Biosciences, Inc. | 517.86M | -0.74% | 481,089 | 204.17M |
| 447 | CERS | Cerus Corporation | 516.95M | -0.77% | 871,170 | 216.56M |
| 448 | ALT | Altimmune, Inc. | 516.33M | -2.75% | 1,370,509 | 36.00K |
| 449 | PRME | Prime Medicine, Inc. | 514.76M | -3.72% | 1,053,075 | 4.03M |
| 450 | DNA | Ginkgo Bioworks Holdings, Inc. | 511.49M | -3.21% | 429,548 | 151.40M |
| 451 | PROK | ProKidney Corp. | 507.46M | -1.75% | 197,457 | 889.00K |
| 452 | VALN | Valneva SE | 506.31M | -1.41% | 9,301 | 180.25M |
| 453 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 454 | CLYM | Climb Bio, Inc. | 501.57M | -2.51% | 1,375,002 | - |
| 455 | ANGO | AngioDynamics, Inc. | 498.52M | 0.25% | 73,625 | 313.73M |
| 456 | CABA | Cabaletta Bio, Inc. | 494.06M | -5.31% | 1,282,997 | - |
| 457 | AGMB | AgomAb Therapeutics NV | 491.86M | -3.13% | 62,087 | - |
| 458 | AQST | Aquestive Therapeutics, Inc. | 489.26M | -0.26% | 528,380 | 50.27M |
| 459 | TOI | The Oncology Institute, Inc. | 487.92M | -3.75% | 764,784 | 545.76M |
| 460 | SRTA | Strata Critical Medical, Inc. | 478.49M | -5.79% | 537,229 | 228.58M |
| 461 | KIDS | OrthoPediatrics Corp. | 471.06M | 0.60% | 32,667 | 243.30M |
| 462 | FDMT | 4D Molecular Therapeutics, Inc. | 467.09M | 3.41% | 216,220 | 88.24M |
| 463 | KYTX | Kyverna Therapeutics, Inc. | 466.08M | -0.13% | 344,978 | - |
| 464 | EIKN | Eikon Therapeutics, Inc. | 464.78M | -4.40% | 82,248 | - |
| 465 | CTEV | Claritev Corporation | 463.27M | 0.39% | 16,503 | 978.76M |
| 466 | ARVN | Arvinas, Inc. | 460.04M | -0.28% | 485,376 | 89.40M |
| 467 | VREX | Varex Imaging Corporation | 445.49M | 2.72% | 83,538 | 857.50M |
| 468 | ASMB | Assembly Biosciences, Inc. | 444.70M | -0.51% | 58,507 | 71.10M |
| 469 | OVID | Ovid Therapeutics Inc. | 442.34M | 0.42% | 565,285 | 7.12M |
| 470 | NRC | NRC Health | 441.61M | 1.37% | 36,499 | 138.64M |
| 471 | EOLS | Evolus, Inc. | 438.92M | -0.22% | 268,105 | 301.79M |
| 472 | PRTA | Prothena Corporation plc | 438.20M | -2.22% | 158,968 | 57.94M |
| 473 | WEAV | Weave Communications, Inc. | 438.01M | -2.91% | 255,369 | 248.72M |
| 474 | CTNM | Contineum Therapeutics, Inc. | 434.06M | 0.69% | 34,293 | - |
| 475 | NGNE | Neurogene Inc. | 431.23M | -4.58% | 246,505 | 925.00K |
| 476 | KMDA | Kamada Ltd. | 422.76M | 0.35% | 5,434 | 181.68M |
| 477 | MOBI | Mobia Medical, Inc. | 422.17M | 0.47% | 53,572 | 32.04M |
| 478 | OCGN | Ocugen, Inc. | 421.46M | -1.19% | 1,727,916 | 4.47M |
| 479 | PACB | Pacific Biosciences of California, Inc. | 417.76M | -2.54% | 1,580,146 | 160.03M |
| 480 | STRO | Sutro Biopharma, Inc. | 417.74M | -0.79% | 59,898 | 99.61M |
| 481 | MYGN | Myriad Genetics, Inc. | 414.16M | -0.11% | 204,278 | 829.00M |
| 482 | CCRN | Cross Country Healthcare, Inc. | 409.00M | 0.08% | 155,660 | 1.00B |
| 483 | RZLT | Rezolute, Inc. | 403.76M | -5.27% | 647,956 | - |
| 484 | SGMT | Sagimet Biosciences Inc. | 400.77M | -0.61% | 198,457 | - |
| 485 | MNPR | Monopar Therapeutics Inc. | 398.24M | -1.91% | 82,751 | - |
| 486 | CLPT | ClearPoint Neuro, Inc. | 396.16M | -1.27% | 110,301 | 40.61M |
| 487 | EBS | Emergent BioSolutions Inc. | 395.74M | -4.13% | 282,977 | 676.80M |
| 488 | VTVT | vTv Therapeutics Inc. | 394.00M | -0.97% | 8,521 | 36.84M |
| 489 | ANL | Adlai Nortye Ltd. | 393.52M | -3.83% | 20,094 | 5.00M |
| 490 | CGC | Canopy Growth Corporation | 393.11M | -0.01% | 4,413,611 | 203.04M |
| 491 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.90M | -0.17% | 75,756 | - |
| 492 | EDIT | Editas Medicine, Inc. | 392.86M | -3.21% | 791,980 | 38.69M |
| 493 | DCTH | Delcath Systems, Inc. | 392.51M | 3.93% | 366,462 | 90.44M |
| 494 | CCCC | C4 Therapeutics, Inc. | 392.24M | -0.84% | 755,997 | 34.86M |
| 495 | OFIX | Orthofix Medical Inc. | 391.69M | - | 82,171 | 825.37M |
| 496 | IPSC | Century Therapeutics, Inc. | 387.76M | 1.42% | 269,644 | 109.16M |
| 497 | TBRG | TruBridge, Inc. | 385.76M | 0.06% | 159,562 | 345.90M |
| 498 | FBRX | Forte Biosciences, Inc. | 384.86M | 0.51% | 101,508 | - |
| 499 | CYH | Community Health Systems, Inc. | 382.66M | 2.36% | 404,186 | 12.29B |
| 500 | VMD | Viemed Healthcare, Inc. | 382.22M | 0.50% | 41,877 | 286.57M |